1. Home
  2. MCRB vs QRHC Comparison

MCRB vs QRHC Comparison

Compare MCRB & QRHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MCRB
  • QRHC
  • Stock Information
  • Founded
  • MCRB 2010
  • QRHC N/A
  • Country
  • MCRB United States
  • QRHC United States
  • Employees
  • MCRB N/A
  • QRHC N/A
  • Industry
  • MCRB Biotechnology: Pharmaceutical Preparations
  • QRHC Environmental Services
  • Sector
  • MCRB Health Care
  • QRHC Utilities
  • Exchange
  • MCRB Nasdaq
  • QRHC Nasdaq
  • Market Cap
  • MCRB 81.2M
  • QRHC 92.0M
  • IPO Year
  • MCRB 2015
  • QRHC N/A
  • Fundamental
  • Price
  • MCRB $7.06
  • QRHC $2.49
  • Analyst Decision
  • MCRB Hold
  • QRHC Strong Buy
  • Analyst Count
  • MCRB 5
  • QRHC 2
  • Target Price
  • MCRB $73.67
  • QRHC $12.75
  • AVG Volume (30 Days)
  • MCRB 146.8K
  • QRHC 76.6K
  • Earning Date
  • MCRB 05-07-2025
  • QRHC 05-12-2025
  • Dividend Yield
  • MCRB N/A
  • QRHC N/A
  • EPS Growth
  • MCRB N/A
  • QRHC N/A
  • EPS
  • MCRB 0.03
  • QRHC N/A
  • Revenue
  • MCRB N/A
  • QRHC $288,532,000.00
  • Revenue This Year
  • MCRB N/A
  • QRHC $7.55
  • Revenue Next Year
  • MCRB N/A
  • QRHC $7.03
  • P/E Ratio
  • MCRB $213.09
  • QRHC N/A
  • Revenue Growth
  • MCRB N/A
  • QRHC 0.05
  • 52 Week Low
  • MCRB $7.18
  • QRHC $1.91
  • 52 Week High
  • MCRB $30.60
  • QRHC $10.51
  • Technical
  • Relative Strength Index (RSI)
  • MCRB 33.07
  • QRHC 48.54
  • Support Level
  • MCRB $8.92
  • QRHC $2.14
  • Resistance Level
  • MCRB $9.97
  • QRHC $2.51
  • Average True Range (ATR)
  • MCRB 1.08
  • QRHC 0.20
  • MACD
  • MCRB -0.06
  • QRHC 0.07
  • Stochastic Oscillator
  • MCRB 10.61
  • QRHC 69.81

About MCRB Seres Therapeutics Inc.

Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.

About QRHC Quest Resource Holding Corporation

Quest Resource Holding Corp is a national provider of waste and recycling services to customers from across multiple industry sectors that are typically larger, multi-location businesses. The company creates customer-specific programs and perform the related services for the collection, processing, recycling, disposal, and tracking of waste streams and recyclables. The company's services focus on the waste streams and recyclables from box, grocers, and other specialty retailers; automotive after-market operations such as automotive maintenance, quick lube, dealerships, and collision repair; transportation, logistics, and fleet operators; manufacturing and industrial facilities; multi-family and commercial properties; restaurant chains and food operations.

Share on Social Networks: